This blog is related to the various litigations related to patents w.r.t pharma industry.
Monday, August 24, 2009
Ranbaxy gets US FDA nod for glycopyrrolate tabs to treat peptic ulcer
Ranbaxy Laboratories Limited (RLL), has received approval from the US Food and Drug Administration (US FDA) to manufacture and market glycopyrrolate tablets USP, 1 mg and 2 mg.
No comments:
Post a Comment